Breast Cancer Profiling Project, Drug Sensitivity phase I: Fixed-cell GR measures of 35 breast cell lines to 34 small molecule perturbagens from library plate I. Dataset 2 of 2: Calculated dose response metrics - Dataset (ID:20344)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Primary Target | Pathway | GR50 | GRmax | GR_AOC | Death_AUC | GR Hill Coefficient | GEC50 | GR r2 |
---|---|---|---|---|---|---|---|---|---|---|
HCC70 | Ipatasertib | AKT | PI3K/mTOR | 0.1397 | -0.2624 | 0.4974 | 0.0860 | 0.8534 | 0.21677 | 0.98567 |
HCC70 | Alpelisib | PI3Ka | PI3K/mTOR | 4.4987 | 0.0981 | 0.1182 | 0.0196 | 1.0448 | 12.8744 | 0.95143 |
HCC70 | Taselisib | PI3Ka, g, d | PI3K/mTOR | 0.15092 | -0.6846 | 0.5796 | 0.1546 | 0.7043 | 0.64661 | 0.98584 |
HCC70 | TGX221 | PI3Kb | PI3K/mTOR | 0.092754 | 0.0049 | 0.4729 | 0.0591 | 0.8818 | 0.076452 | 0.9787 |
HCC70 | Torin2 | mTOR/ATM/ATR | PI3K/mTOR | 0.0058452 | -0.5550 | 0.6451 | 0.1234 | 0.5307 | 0.026938 | 0.94991 |
HCC70 | Everolimus | mTOR1 | PI3K/mTOR | 0.24351 | 0.3727 | 0.4764 | 0.0448 | 0.1135 | 51.0339 | 0.79604 |
HCC70 | INK-128 | mTORC1/2 | PI3K/mTOR | 0.0048011 | -0.1620 | 0.7024 | 0.0912 | 1.1840 | 0.0050026 | 0.97794 |
HCC70 | PF-4708671 | p70S6K | PI3K/mTOR | Inf | 0.9348 | -0.0227 | 0.0035 | 0.0000 | Inf | 0.040075 |
HCC70 | Buparlisib | pan PI3K | PI3K/mTOR | 0.43342 | -0.7274 | 0.4614 | 0.1434 | 1.1927 | 1.0047 | 0.99537 |
HCC70 | Pictilisib | pan PI3K | PI3K/mTOR | 0.16052 | -0.5972 | 0.5726 | 0.1167 | 0.7256 | 0.58082 | 0.99601 |
HCC70 | Ceritinib | ALK | RTK | 3.1923 | -0.8808 | 0.1379 | 0.0703 | 5.0000 | 3.9213 | 0.99483 |
HCC70 | Neratinib | EGFR/HER2 | RTK | 0.16013 | 0.0595 | 0.3178 | 0.0405 | 1.0555 | 0.15156 | 0.99467 |
HCC70 | Tivantinib | MET | RTK | 0.3335 | -0.5657 | 0.4968 | 0.1515 | 2.0000 | 0.48673 | 0.99617 |
HCC70 | Cediranib | VEGFR/cKIT | RTK | 4.5386 | -0.3262 | 0.0890 | 0.0440 | 2.2440 | 7.4053 | 0.99062 |
HCC70 | Cabozantinib | VEGFR2/MET | RTK | 1.5024 | -0.0911 | 0.2658 | 0.0226 | 0.5892 | 9.6961 | 0.92355 |
PDX1258 | Abemaciclib | CDK4/6 | Cell cycle | 0.67289 | -0.3305 | 0.3350 | 0.0542 | 1.0569 | 1.2734 | 0.99626 |
PDX1258 | Palbociclib | CDK4/6 | Cell cycle | Inf | 1.0159 | -0.0479 | 0.0014 | 0.0000 | Inf | -18.593 |
PDX1258 | AZD7762 | CHK1/2 | Cell cycle | 0.014946 | -0.4528 | 0.9199 | 0.3234 | 1.6838 | 0.021221 | 0.99249 |
PDX1258 | Volasertib | PLK | Cell cycle | 0.0073734 | -0.2320 | 0.5602 | 0.1765 | 1.8198 | 0.0083258 | 0.98847 |
PDX1258 | Dinaciclib | pan CDK | Cell cycle | 0.011566 | -0.6173 | 0.7036 | 0.2838 | 3.5943 | 0.014366 | 0.99779 |
PDX1258 | Cisplatin | Chemo | Chemotherapy | 2.5568 | 0.3181 | 0.1555 | 0.0433 | 1.6027 | 1.5449 | 0.99079 |
PDX1258 | Doxorubicin | Chemo | Chemotherapy | 0.0091389 | -0.4928 | 0.7540 | 0.2368 | 1.1844 | 0.013938 | 0.97567 |
PDX1258 | Taxol | Chemo | Chemotherapy | 0.0021522 | -0.0818 | 0.6797 | 0.2357 | 1.2501 | 0.0022935 | 0.98829 |
PDX1258 | Topotecan | Topo I | Chemotherapy | 0.013472 | -0.4565 | 0.8673 | 0.2817 | 0.8122 | 0.026852 | 0.98013 |
PDX1258 | Etoposide | Topo II | Chemotherapy | 0.31701 | -0.1807 | 0.3942 | 0.1360 | 1.0906 | 0.41876 | 0.99346 |